Cargando…
Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease
Dengue virus (DENV) infection causes serious health problems in humans for which no drug is currently available. Recently, DENV NS2B-NS3 protease has been proposed as a primary target for anti-dengue drug discovery due to its important role in new virus particle formation by conducting DENV polyprot...
Autores principales: | Bharadwaj, Shiv, Lee, Kyung Eun, Dwivedi, Vivek Dhar, Yadava, Umesh, Panwar, Aleksha, Lucas, Stuart. J., Pandey, Amit, Kang, Sang Gu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911040/ https://www.ncbi.nlm.nih.gov/pubmed/31836806 http://dx.doi.org/10.1038/s41598-019-55723-5 |
Ejemplares similares
-
Discovery of Bispecific Lead Compounds from Azadirachta indica against ZIKA NS2B-NS3 Protease and NS5 RNA Dependent RNA Polymerase Using Molecular Simulations
por: Kumar, Sanjay, et al.
Publicado: (2022) -
Triterpenoids from the spores of Ganoderma lucidum
por: Ma, Bingji, et al.
Publicado: (2011) -
Identification of a Novel Metabolic Target for Bioactive Triterpenoids Biosynthesis in Ganoderma lucidum
por: Xu, Juan, et al.
Publicado: (2022) -
Design of New Competitive Dengue Ns2b/Ns3 Protease Inhibitors—A Computational Approach
por: Frimayanti, Neni, et al.
Publicado: (2011) -
Computer Aided Screening of Phytochemicals from Garcinia against the Dengue NS2B/NS3 Protease
por: Qamar, Tahir ul, et al.
Publicado: (2014)